Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report

Aims Practical management guidelines for impaired glucose tolerance(IGT) have not been established. Although IGT is a potent marker of cardiovascular disease (CVD), it is still controversial whether its magnitude of CVD risk is comparable to that of frank diabetes. Moreover, information on long-term clinical outcomes of IGT patients undergoing coronary revascularizationis limited. The aim of the present work was to investigate the 10-year prognostic impact of IGT in comparison with diabetes in patients with CAD undergoing coronary revascularization.